Profit Or Loss [Abstract]

Sopharma AD - Filing #6022429

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
1 663 016 BGN
1 603 310 BGN
Cost of sales
1 214 333 BGN
1 166 508 BGN
Profit (loss) from operating activities
87 881 BGN
63 519 BGN
Finance income
3 304 BGN
6 632 BGN
Finance costs
9 417 BGN
11 797 BGN
Share of profit (loss) of associates and joint ventures accounted for using equity method
22 635 BGN
12 092 BGN
Profit (loss) before tax
85 076 BGN
97 574 BGN
Tax expense (income)
8 743 BGN
5 871 BGN
Profit (loss)
71 121 BGN
76 333 BGN
71 121 BGN
5 212 BGN
2 207 BGN
89 496 BGN
91 703 BGN
89 496 BGN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
71 121 BGN
89 496 BGN
Profit (loss), attributable to non-controlling interests
5 212 BGN
2 207 BGN
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.5900
0.7100
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.5700
0.7100

Talk to a Data Expert

Have a question? We'll get back to you promptly.